An individual who carries a pathogenic variant (also known as a mutation) in any one of four different genes (LDLR/APOB/PCSK9/APOE) has heterozygous FH (HeFH), whereas individuals who carry two copies have homozygous FH (HoFH). This evidence concerns the gene PCSK9 and familial hyperaldosteronism.